Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of natural compounds as potent inhibitors of SARS-CoV-2 main protease using combined docking and molecular dynamics simulations
Deeba Shamim Jairajpuri, Afzal Hussain, Khalida Nasreen, et al.
Saudi Journal of Biological Sciences (2021) Vol. 28, Iss. 4, pp. 2423-2431
Open Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of ACEIs Against SARS-CoV-2 Targeting the hACE2 Receptor
Ahmed A. Al‐Karmalawy, Mohammed A. Dahab, Ahmed M. Metwaly, et al.
Frontiers in Chemistry (2021) Vol. 9
Open Access | Times Cited: 200
Natural products can be used in therapeutic management of COVID-19: Probable mechanistic insights
Sabeeha Ali, Manzar Alam, Fatima Khatoon, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 147, pp. 112658-112658
Open Access | Times Cited: 75
Inhibition of the main protease of SARS-CoV-2 (Mpro) by repurposing/designing drug-like substances and utilizing nature’s toolbox of bioactive compounds
Io Antonopoulou, Eleftheria Sapountzaki, Ulrika Rova, et al.
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 1306-1344
Open Access | Times Cited: 65
Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2
Kaifu Gao, Rui Wang, Jiahui Chen, et al.
Chemical Reviews (2022) Vol. 122, Iss. 13, pp. 11287-11368
Open Access | Times Cited: 58
In vitroand computational investigations of novel synthetic carboxamide-linked pyridopyrrolopyrimidines with potent activity as SARS-CoV-2-MProinhibitors
Ateyatallah Aljuhani, Hany E. A. Ahmed, Saleh Ihmaid, et al.
RSC Advances (2022) Vol. 12, Iss. 41, pp. 26895-26907
Open Access | Times Cited: 39
Discovery of Potential KRAS‐SOS1 Inhibitors from South African Natural Compounds: An In silico Approach
Abdul Rashid Issahaku, Elliasu Y. Salifu, Clement Agoni, et al.
ChemistrySelect (2023) Vol. 8, Iss. 24
Closed Access | Times Cited: 32
Computational approaches for modeling and structural design of biological systems: A comprehensive review
Ekambaram Gayathiri, Palanisamy Prakash, Priya Kumaravel, et al.
Progress in Biophysics and Molecular Biology (2023) Vol. 185, pp. 17-32
Closed Access | Times Cited: 29
Molecular hybrids based on 1,2,3-triazole and 1,3,4-thiadiazole cores: Synthesis, characterization, anticancer activity and in silico study
Ali Oubella, Abdoullah Bimoussa, Md Tabish Rehman, et al.
Journal of Molecular Structure (2024) Vol. 1311, pp. 138339-138339
Closed Access | Times Cited: 7
Therapeutic implications and clinical manifestations of thymoquinone
Manzar Alam, Gulam Mustafa Hasan, Md. Meraj Ansari, et al.
Phytochemistry (2022) Vol. 200, pp. 113213-113213
Closed Access | Times Cited: 30
Elucidating the therapeutic potential of indazole derivative bindarit against K-ras receptor: An in-silico analysis using molecular dynamics exploration
Parmar Keshri Nandan, Sivaraman Jayanthi
Biochemistry and Biophysics Reports (2025) Vol. 41, pp. 101913-101913
Closed Access
Insights into SARS-CoV-2 structure: Approaches and action of SARS-CoV-2 main protease inhibitor
Ilma Shakeel, Aaliya Taiyab, Aanchal Rathi, et al.
Elsevier eBooks (2025), pp. 89-117
Closed Access
Identification of Novel Progesterone Receptor (PR) Inhibitors (Homo sapiens) from Metabolites of Biotransformation Fungal: A Bioinformatics Approach
Janaína de Araújo E. Dourado, Samuel Q. Lopes, David Esteban Quintero Jimenez, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 136-136
Open Access
Structure-guided identification of mitogen-activated protein kinase-1 inhibitors towards anticancer therapeutics
Md Nayab Sulaimani, Sayeed Ahmed, Farah Anjum, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0311954-e0311954
Open Access
Unlocking the potential of in silico approach in designing antibodies against SARS-CoV-2
Tasshitra R. Subramaniam, Siti Aisyah Mualif, Weng Howe Chan, et al.
Frontiers in Bioinformatics (2025) Vol. 5
Open Access
Decoding SARS‐CoV‐2 Inhibition: Insights From Molecular Dynamics Simulation of Condensed Amino Thiourea Scaffold Small Molecules
Xiaoli Shen, Hao Zhang, Pengyin Zhang, et al.
Journal of Cellular Biochemistry (2025) Vol. 126, Iss. 2
Closed Access
Design, Synthesis of Imidazole Scaffolds as an Effective Larvicidal Agent Against Etiella Zinkenella and in Vitro Antibacterial and Antifungal Evaluation Against Candida Albicans with Dft Calculations, Molecular Docking Technique and Theoretical Biological Potential
Manoj R. Gaware, Ankita M. Rayate, Dnyaneshwar Lokhande, et al.
(2025)
Closed Access
Discovery of Potent Parthenolide Derivatives Against Triple‐Negative Breast Cancer Using 3D‐QSAR, Virtual Screening, and Molecular Dynamics
Faiza Asli, Saida Khamoulı, Md Tabish Rehman, et al.
ChemistrySelect (2025) Vol. 10, Iss. 9
Closed Access
Identification of Phytoconstituents as Potent Inhibitors of Casein Kinase-1 Alpha Using Virtual Screening and Molecular Dynamics Simulations
Alaa Shafie, Shama Khan, Zehra, et al.
Pharmaceutics (2021) Vol. 13, Iss. 12, pp. 2157-2157
Open Access | Times Cited: 36
An understanding of coronavirus and exploring the molecular dynamics simulations to find promising candidates against the Mpro of nCoV to combat the COVID-19: A systematic review
Madhur Babu Singh, Ritika Sharma, Durgesh Kumar, et al.
Journal of Infection and Public Health (2022) Vol. 15, Iss. 11, pp. 1326-1349
Open Access | Times Cited: 22
Identification of High-Affinity Inhibitors of TANK-Binding Kinase 1 (TBK1): A Promising Frontier for Controlling Inflammatory Signaling in Cancer
Deeba Shamim Jairajpuri, Taj Mohammad, Afzal Hussain, et al.
Discovery Medicine (2024) Vol. 36, Iss. 180, pp. 129-129
Open Access | Times Cited: 4
Thymoquinone and quercetin induce enhanced apoptosis in non‐small cell lung cancer in combination through the Bax/Bcl2 cascade
Shoaib Alam, Taj Mohammad, Rayees Ahmad Padder, et al.
Journal of Cellular Biochemistry (2021) Vol. 123, Iss. 2, pp. 259-274
Closed Access | Times Cited: 31
Identification of intrinsically disorder regions in non-structural proteins of SARS-CoV-2: New insights into drug and vaccine resistance
Farah Anjum, Taj Mohammad, Purva Asrani, et al.
Molecular and Cellular Biochemistry (2022) Vol. 477, Iss. 5, pp. 1607-1619
Open Access | Times Cited: 21
Investigating binding mechanism of thymoquinone to human transferrin, targeting Alzheimer's disease therapy
Bin Xue, Debarati DasGupta, Manzar Alam, et al.
Journal of Cellular Biochemistry (2022) Vol. 123, Iss. 8, pp. 1381-1393
Closed Access | Times Cited: 19
Inhibiting Cyclin-Dependent Kinase 6 by Taurine: Implications in Anticancer Therapeutics
Mohd Yousuf, Anas Shamsi, Taj Mohammad, et al.
ACS Omega (2022) Vol. 7, Iss. 29, pp. 25844-25852
Open Access | Times Cited: 19
Characterization of Plant-Derived Natural Inhibitors of Dipeptidyl Peptidase-4 as Potential Antidiabetic Agents: A Computational Study
Alomgir Hossain, Md. Ekhtiar Rahman, Md Omar Faruqe, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 483-483
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top